KR20070119497A - Cosmetic or plastic composition comprising multipotent stem cells derived from human adipose tissue, fibroblast and adipose or adiopocyte - Google Patents

Cosmetic or plastic composition comprising multipotent stem cells derived from human adipose tissue, fibroblast and adipose or adiopocyte Download PDF

Info

Publication number
KR20070119497A
KR20070119497A KR1020070053275A KR20070053275A KR20070119497A KR 20070119497 A KR20070119497 A KR 20070119497A KR 1020070053275 A KR1020070053275 A KR 1020070053275A KR 20070053275 A KR20070053275 A KR 20070053275A KR 20070119497 A KR20070119497 A KR 20070119497A
Authority
KR
South Korea
Prior art keywords
stem cells
derived
fat
adult stem
adipose
Prior art date
Application number
KR1020070053275A
Other languages
Korean (ko)
Other versions
KR100788632B1 (en
Inventor
라정찬
Original Assignee
주식회사 알앤엘바이오
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 알앤엘바이오 filed Critical 주식회사 알앤엘바이오
Publication of KR20070119497A publication Critical patent/KR20070119497A/en
Application granted granted Critical
Publication of KR100788632B1 publication Critical patent/KR100788632B1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662Stem cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0656Adult fibroblasts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/60Materials for use in artificial skin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0653Adipocytes; Adipose tissue
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662Stem cells
    • C12N5/0667Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/32Amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/01Modulators of cAMP or cGMP, e.g. non-hydrolysable analogs, phosphodiesterase inhibitors, cholera toxin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30Hormones
    • C12N2501/33Insulin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30Hormones
    • C12N2501/38Hormones with nuclear receptors
    • C12N2501/39Steroid hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Rheumatology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Transplantation (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Cosmetics (AREA)

Abstract

A composition comprising human adipose tissue-derived adult stem cells, fibroblasts and adipose or adipocytes is provided to be useful for cosmetic purposes such as skin tightness improvement, wrinkle and flabby skin improvement, and depressed area restoration through plastic surgery as well as useful for the formation of new breast tissue due to the adult stem cells capable of being differentiated into fat cells. A composition for cosmetic or plastic surgery comprises human adipose tissue-derived adult stem cells, fibroblasts and adipose or adipocytes. A method for preparing the composition comprises the steps of: (a) culturing an adipose-containing suspension obtained from human adipose tissue by liposuction in a culture flask and then collecting cell layers comprising both adipose-derived adult stem cells and fibroblasts, which are attached on the surface of the culture flask; and (b) mixing the collected cell layers with adipose or adipocytes, wherein the adult stem cells are mesoderm-derived cells and the adipose-derived adult stem cells are cultured in an alpha-MEM medium including dexamethasone, indomethacin, insulin and IBMX to differentiate into adipogenic cells.

Description

인간 지방조직 유래 다분화능 줄기세포, 섬유아세포 및 지방 또는 지방세포를 함유한 피부미용 또는 성형용 조성물의 제조방법{Cosmetic or Plastic Composition Comprising Multipotent Stem Cells Derived from Human Adipose Tissue, Fibroblast and Adipose or Adiopocyte}Method for producing skin cosmetic or cosmetic composition containing human adipose tissue-derived multipotent stem cells, fibroblasts and adipose or fat cells {Cosmetic or Plastic Composition Comprising Multipotent Stem Cells Derived from Human Adipose Tissue, Fibroblast and Adipose or Adiopocyte}

도 1은 본 발명에 따른 인간 지방조직 유래 다분화능 줄기세포, 섬유아세포 등을 포함한 플라스크에 부착하는 세포를 100배 배율로 촬영한 사진이다. 1 is a photograph taken at 100-fold magnification of cells attached to a flask including human adipose tissue-derived multipotent stem cells, fibroblasts, and the like according to the present invention.

도 2는 본 발명에 따른 인간 지방조직 유래 다분화능 줄기세포를 CORM-2 함유 MEBM 배지에서 sphere culture한 후 면역염색을 이용하여 Nestin, Oct4, SH2, SH3/4가 발현한 결과를 100배 배율로 나타낸 사진이다. 2 is a 100-fold magnification of the expression of Nestin, Oct4, SH2, and SH3 / 4 using immunostaining after sphere culture of human adipose tissue-derived multipotent stem cells according to the present invention in CORM-2-containing MEBM medium. The picture shown.

도 3은 본 발명에 따른 인간 지방조직 유래 다분화능 줄기세포로부터 분화된 지방세포를 200배 배율로 나타낸 것이다 (A: 분화된 상태의 phase contrast, B: Oil Red O 염색법으로 염색한 것). Figure 3 shows the adipocytes differentiated from human adipose tissue-derived multipotent stem cells according to the present invention at a 200-fold magnification (A: phase contrast of the differentiated state, B: stained by Oil Red O staining method).

본 발명은 인간 지방 조직 유래 성체 줄기세포, 섬유아세포 및 지방 또는 지방세포를 함유하는 피부 미용 또는 성형용 조성물 그 제조방법에 관한 것이다.The present invention relates to a method for producing a composition for cosmetic or cosmetic skin containing adult stem cells, fibroblasts and fat or fat cells derived from human adipose tissue.

줄기세포(stem cell)란 자기 복제 능력을 가지면서 두 개 이상의 세포로 분화하는 능력을 갖는 세포로, 만능 줄기세포(totipotent stem cell), 전분화능 줄기세포(pluripotent stem cells), 다분화능 줄기세포(multipotent stem cells)로 분류할 수 있다. Stem cells are cells that have the ability to self-replicate and differentiate into two or more cells. Totipotent stem cells, pluripotent stem cells, and multipotent stem cells ( multipotent stem cells).

최근, 지방 조직이 다분화능 줄기세포의 새로운 소스임이 밝혀졌다 (B. Cousin et al ., BBRC, 301:1016, 2003; A. Miranville et al ., Circulation , 110:349, 2004; S. Gronthos et al ., J. Cell Physiol., 189:54, 2001; M.J. Seo et al ., BBRC, 328:258, 2005). 즉, 지방추출(지방흡입술(liposuction))에 의해 얻어진 인간 지방조직에 미분화 세포군이 포함되어 있고, 이것이 in vitro상에서 지방세포, 골형성세포, 근원세포 및 연골모세포로의 분화능을 갖는다는 것이 보고되었다 (P.A. Zuk et al ., Tissue Eng ., 7:211, 2001; A.M. Rodriguez et al ., BBRC, 315:255, 2004). 아울러 지방 조직 유래 세포가 근육 재생능 및 신경혈관분화를 촉진하는 능력이 있다는 것이 동물 모델 실험을 통하여 알려진 바 있다. 이러한 지방 조직은 대량으로 추출할 수 있다는 장점이 있어, 기존의 단점을 보완하는 새로운 줄기세포의 소스로 주목받고 있다. Recently, adipose tissue has been found to be a new source of pluripotent stem cells (B. Cousin et. al ., BBRC , 301: 1016, 2003; A. Miranville et al ., Circulation , 110: 349, 2004; S. Gronthos et al ., J. Cell Physiol ., 189: 54, 2001; MJ Seo et al ., BBRC , 328: 258, 2005). That is, it has been reported that undifferentiated cell populations are included in human adipose tissue obtained by liposuction (liposuction) and have differentiation ability into adipocytes, osteoblasts, myoblasts and chondrocytes in vitro. (PA Zuk et al ., Tissue Eng . , 7: 211, 2001; AM Rodriguez et al ., BBRC , 315: 255, 2004). In addition, it has been known through animal model experiments that adipose tissue-derived cells have the ability to promote muscle regeneration and neurovascular differentiation. These adipose tissues have the advantage that they can be extracted in large quantities, attracting attention as a source of new stem cells to supplement the existing disadvantages.

지금까지 알려진 지방 유래 줄기세포로는 상피세포로 분화가능한 인간 지방 유래 성체 줄기 세포 (M. Brzoska et al., BBRC, 330:142, 2005), 골 형성 및 지방 세포로 분화가능한 인간 지방 유래 성체 줄기세포 (Y. Cao et al., BBRC, 332:370, 2005), 신경세포로 분화가능한 인간 지방 유래 성체 줄기세포 (K.M. Safford et al ., BBRC, 294:371, 2005), 지방세포로 분화가능한 쥐 지방 유래 줄기세포 (R. Ogawa et al ., BBRC, 319:511, 2004), 골 형성 및 연골 형성세포로 분화가능한 쥐 지방 유래 줄기세포 (R. Ogawa et al ., BBRC, 313:871, 2004), 연골세포로 분화가능한 인간 지방 유래 줄기세포 (H.A. Awad et al., Biomaterials, 25:3211, 2004), 신경 세포로 분화가능한 쥐 지방 유래 줄기세포 (J. Fujimura et al ., BBRC, 333:116, 2005) 및 골세포, 연골세포, 신경세포 또는 근육세포로 분화가능한 지방 유래 줄기세포 (미국특허 6,777,231) 등이 있다. So far known adipose derived stem cells include human adipose derived adult stem cells capable of differentiating into epithelial cells (M. Brzoska et. al ., BBRC , 330: 142, 2005), human adipose derived adult stem cells capable of bone formation and differentiation into adipocytes (Y. Cao et. al ., BBRC , 332: 370, 2005), human adipose derived stem cells capable of differentiation into neurons (KM Safford et al ., BBRC , 294: 371, 2005), mouse adipose derived stem cells capable of differentiating into adipocytes ( R. Ogawa et al ., BBRC , 319: 511, 2004), rat adipose derived stem cells capable of differentiating into bone formation and chondrogenic cells (R. Ogawa et. al ., BBRC , 313: 871, 2004), human adipose derived stem cells capable of differentiation into chondrocytes (HA Awad et. al ., Biomaterials , 25: 3211, 2004), mouse adipose derived stem cells capable of differentiating into neurons (J. Fujimura et. al ., BBRC , 333: 116, 2005) and adipose derived stem cells capable of differentiating into osteoblasts, chondrocytes, neurons or muscle cells (US Pat. No. 6,777,231).

현재까지 이러한 지방 유래 줄기세포는 주로 난치병 등의 치료를 포함한 의학 분야에서 이용하고자 하는 노력이 계속되었으나, 미용 또는 성형을 목적으로 줄기세포를 이용하고자 하는 시도는 미비하였다. Until now, efforts to use these fat-derived stem cells in the medical field including treatment of intractable diseases have been continued, but attempts to use stem cells for cosmetic or cosmetic purposes have been insufficient.

이에 본 발명자들은 주름 개선, 피부의 처짐 방지 등의 미용 및 성형 분야에 줄기세포를 이용하고자 예의 노력한 결과, 지방흡입술 (liposuction)으로부터 얻어진 지방 함유 suspension을 배양하여 성체 줄기세포 및 섬유아세포 함유 세포층을 회수한 다음, 지방과 혼합한 결과, 미용 및 성형에 효과적이라는 것을 확인하고, 본 발명을 완성하게 되었다. Accordingly, the present inventors have made efforts to use stem cells in cosmetic and cosmetic fields such as wrinkle improvement and prevention of sagging of skin. As a result, the adult stem cells and fibroblast-containing cell layers are recovered by culturing a fat-containing suspension obtained from liposuction. Then, as a result of mixing with fat, it was confirmed that it is effective for beauty and shaping, and completed the present invention.

본 발명의 목적은 인간 지방 조직 유래 성체 줄기세포, 섬유 아세포 및 지방 또는 지방세포를 함유하는 미용 또는 성형용 조성물 및 그 제조방법을 제공하는데 있다. An object of the present invention is to provide a composition for cosmetic or cosmetic containing adult stem cells, fibroblasts and fat or adipocytes derived from human adipose tissue and a method for producing the same.

상기의 목적을 달성하기 위하여, 본 발명은 (a) 인간 지방 조직의 지방흡입술 (liposuction)에 의해 얻어진 지방 함유 suspension을 배양용기에서 배양한 다음, 상기 배양용기에 부착된 지방 유래 성체 줄기세포 및 섬유아세포 함유 세포층을 회수하는 단계; 및 (b) 상기 회수된 지방 유래 성체 줄기세포 및 섬유아세포 함유 세포층을 지방 또는 지방세포와 혼합하는 단계를 포함하는, (i) 인간 지방 조직 유래 성체 줄기세포, (ii) 섬유아세포 및 (iii) 지방 또는 지방세포를 함유하는 피부 미용 또는 성형용 조성물의 제조방법을 제공한다. In order to achieve the above object, the present invention (a) culturing the fat-containing suspension obtained by liposuction of human adipose tissue in a culture vessel, and then adult stem cells and fibers derived from fat attached to the culture vessel Recovering the blast-containing cell layer; And (b) mixing the recovered adipose derived adult stem cells and fibroblast-containing cell layers with fat or adipocytes, (i) human adipose tissue derived adult stem cells, (ii) fibroblasts and (iii) It provides a method for producing a skin cosmetic or cosmetic composition containing fat or fat cells.

본 발명은 또한, (a) 인간 지방조직 유래 펠렛을 NAC(N-acetyl-L-cysteine) 함유 배지에서 배양하여 지방 유래 성체 줄기세포를 제조한 다음, 지방유래 줄기세포와 섬유아세포를 회수하는 단계; 및 (b) 상기 회수된 지방 유래 성체 줄기세포 및 섬유아세포를 지방 또는 지방세포와 혼합하는 단계를 포함하는, (i) 인간 지방 조직 유래 성체 줄기세포, (ii) 섬유아세포 및 (iii) 지방 또는 지방세포를 함유하는 피부 미용 또는 성형용 조성물의 제조방법을 제공한다. The present invention also comprises the steps of (a) culturing human adipose tissue-derived pellets in NAC (N-acetyl-L-cysteine) -containing medium to produce adult stem cells, and then recovering adipose derived stem cells and fibroblasts. ; And (b) mixing the recovered adipose derived adult stem cells and fibroblasts with fat or adipocytes, (i) human adipose tissue derived adult stem cells, (ii) fibroblasts and (iii) fat or It provides a method for producing a skin cosmetic or molding composition containing fat cells.

본 발명은 또한, (i) 인간 지방 조직 유래 성체 줄기세포, (ii) 섬유아세포 및 (iii) 지방 또는 지방세포를 함유하는 피부 미용 또는 성형용 조성물을 제공한다. The present invention also provides a composition for skin beauty or shaping, comprising (i) adult stem cells derived from human adipose tissue, (ii) fibroblasts and (iii) fat or fat cells.

본 발명은 일 관점에서, 인간 지방 조직 유래 성체 줄기세포, 섬유 아세포 및 지방 또는 지방세포를 함유하는 미용 또는 성형용 조성물에 관한 것이다.The present invention, in one aspect, relates to a composition for cosmetic or cosmetic containing adult stem cells, fibroblasts and fat or fat cells derived from human adipose tissue.

본 발명에 따른 조성물은 유방 조직 형성을 통한 가슴 확대용 또는 주름제거용인 것을 특징으로 할 수 있으나, 이에 국한되는 것은 아니다. 예컨대, 미세지방 이식술, 자가지방 이식술 등 얼굴의 얼굴의 팔자 주름 및 미간주름 제거 및 탄력 유지를 목적으로 사용할 수도 있다. 본 발명에 따른 조성물에 함유되는 인간 지방 조직 유래 성체 줄기세포, 섬유 아세포 및 지방은 자가 유래 세포인 것이 바람직하다. The composition according to the present invention may be characterized in that for breast enlargement or wrinkle removal through breast tissue formation, but is not limited thereto. For example, it may be used for the purpose of removing nasolabial folds and forehead wrinkles and maintaining elasticity of the face of the face such as microfat graft and autologous graft. The human adipose tissue-derived adult stem cells, fibroblasts and fat contained in the composition according to the present invention are preferably autologous cells.

본 발명에 따른 미용 또는 성형용 조성물은 인간 지방 조직의 지방흡입술(liposuction)에서 얻어지는 지방 함유 suspension을 배양하여 수득된 지방 유래 성체 줄기세포 및 섬유아세포를 기타 다른 세포 또는 조직과 혼합하여 제조할 수 있다. The cosmetic or cosmetic composition according to the present invention can be prepared by mixing fat-derived adult stem cells and fibroblasts obtained by culturing a fat-containing suspension obtained by liposuction of human adipose tissue with other cells or tissues. .

일 구현예에서, 피부 미용 또는 성형용 조성물은 다음 단계를 거쳐 제조할 수 있다: (a) 인간 지방 조직의 지방흡입술(liposuction)에 의해 얻어진 지방 함유 suspension을 배양용기에서 배양한 다음, 상기 배양용기에 부착된 지방 유래 성체 줄기세포 및 섬유아세포 함유 세포층을 회수하는 단계; 및 (b) 상기 회수된 지방 유래 성체 줄기세포 및 섬유아세포 함유 세포층을 지방 또는 지방세포와 혼합하는 단계.In one embodiment, the skin cosmetic or cosmetic composition may be prepared by the following steps: (a) culturing the fat-containing suspension obtained by liposuction of human adipose tissue in a culture vessel, and then culturing the culture vessel Recovering the adipose derived adult stem cells and fibroblast-containing cell layers attached thereto; And (b) mixing the recovered adipose derived adult stem cells and fibroblast-containing cell layers with fat or adipocytes.

더욱 구체적으로는, 지방흡입술로부터 얻어지는 생리 식염수에 부유된 지방 함유 suspension을 배양한 다음, 플라스크 등 배양용기에 부착된 줄기세포 및 섬유 아세포를 회수 직전에 생리식염수로 1회 세척하여 상층액의 잔여 지방 및 혈구세포 등을 제거하고, 바닥에 부착된 줄기세포 및 섬유아세포 층을 트립신으로 처리한 다음 회수하거나, 스크래퍼로 긁어서 소량의 생리 식염수에 부유되는 것을 직접회수하거나, 또는 원심분리하여 원심분리된 세포층을 회수하여, 지방과 혼합하여 제조한다. More specifically, after culturing a suspension containing fat suspended in physiological saline obtained from liposuction, the stem cells and fibroblasts attached to the culture vessel such as a flask are washed once with physiological saline immediately before recovery, and the remaining fat of the supernatant is recovered. And removing the blood cells and the like, and recovering the stem cells and fibroblast layers attached to the bottom with trypsin, or recovering them by scraping them with a scraper, or directly recovering the suspended solids in a small amount of physiological saline, or centrifuging the cell layer. Is collected and mixed with fat to prepare.

본 발명에 있어서, 상기 성체 줄기세포는 중배엽 유래 세포인 것을 특징으로 할 수 있고, 상기 중배엽 유래 세포는 지방세포인 것을 특징으로 할 수 있다. In the present invention, the adult stem cells may be characterized in that the mesoderm derived cells, the mesoderm derived cells may be characterized in that the adipocytes.

본 발명에 있어서, 상기 성체 줄기세포는 덱사메타손(dexamethasone), 인도메타신(indomethacin), 인슐린 및 IBMX를 함유한 α-MEM 배지에 배양하여 지방세포로 분화되는 것을 특징으로 할 수 있다. In the present invention, the adult stem cells can be characterized by differentiation into adipocytes by culturing in α-MEM medium containing dexamethasone (indamethasone), indomethacin (indomethacin), insulin and IBMX.

다른 구현예에서, 피부 미용 또는 성형용 조성물은 다음 단계를 거쳐 제조할 수 있다: (a) 인간 지방조직 유래 펠렛을 NAC(N-acetyl-L-cysteine) 함유 배지에서 배양하여 지방 유래 성체 줄기세포를 제조한 다음, 지방유래 줄기세포와 섬유아세포를 회수하는 단계; 및 (b) 상기 회수된 지방 유래 성체 줄기세포 및 섬유아세포를 지방 또는 지방세포와 혼합하는 단계.In another embodiment, the skin cosmetic or cosmetic composition may be prepared by the following steps: (a) Adipose-derived adult stem cells by culturing pellets derived from human adipose tissue in a medium containing N-acetyl-L-cysteine (NAC) After preparing, recovering the adipose derived stem cells and fibroblasts; And (b) mixing the recovered adipose derived adult stem cells and fibroblasts with fat or adipocytes.

상기 지방흡입술(liposuction)은 지방 제거의 미용 또는 성형 수술의 한 기법으로서, 지방질 부분을 절개하여 진공 펌프로 지방질을 뽑아내는 것 또는 주사기의 압력으로 뽑아내는 것을 의미한다. The liposuction is a technique of cosmetic or plastic surgery of fat removal, which means cutting the fat portion and extracting the fat by a vacuum pump or by the pressure of a syringe.

본 발명에 있어서, 지방 또는 지방세포는 인간 지방 조직의 지방흡입술 (liposuction)에서 부수적으로 얻어지는 것을 사용할 수 있으나, 이에 국한되는 것 은 아니다. 본 발명에서 지방은 지방조직을 포함한다.In the present invention, fat or adipocytes may be used that is obtained incidentally in liposuction of human adipose tissue, but is not limited thereto. Fat in the present invention includes adipose tissue.

본 발명의 피부 미용 또는 성형용 조성물은 지방을 사용할 경우에는 지방조직은 1ml에 대하여 1×104~1×107개의 지방유래 줄기세포와 섬유아세포를 함유하는 것이 바람직하고, 지방세포를 사용할 경우에는 지방유래 줄기세포와 섬유아세포의 총세포수에 대하여 1~50배의 지방세포를 사용하는 것이 바람직하다.When the skin cosmetic or cosmetic composition of the present invention uses fat, the fat tissue preferably contains 1 × 10 4 to 1 × 10 7 fat-derived stem cells and fibroblasts per 1 ml. It is preferable to use 1 to 50 times the fat cells with respect to the total cell number of the adipose derived stem cells and fibroblasts.

아울러, 섬유아세포(fibroblast)는 섬유성 결합조직의 중요한 성분을 이루는 세포로서, 섬유세포라고도 한다. 조직절편으로 관찰하면 편평하고 길쭉한 외형을 가지며 흔히 불규칙한 돌기를 보인다. 세포질은 미토콘드리아, 골지체, 중심체, 소지방체 등을 포함하고 그 밖에 특수한 분화는 나타내지 않는다. 핵은 염색성이 약하고 타원형이며 인을 함유한다. 교원섬유에 밀접해 있는 경우가 많고, 그 형성에 관계가 있다고 생각되므로 상기와 같은 명칭이 붙었다. 본 발명에서 상기 섬유아세포는 지방조직으로부터 줄기세포를 분리하는 과정에서 함께 분리할 수 있다.In addition, fibroblasts (fibroblast) is an important component of the fibrous connective tissue, also called fibroblasts. Observed by tissue section, it has a flat and elongated appearance and often shows irregular projections. The cytoplasm contains mitochondria, Golgi apparatus, centrosomes, small fat bodies and the like, and does not exhibit any special differentiation. The nucleus is weakly stainable, elliptical, and contains phosphorus. In many cases, it is closely related to collagen fibers, and because it is thought to be related to its formation, the same name is given. In the present invention, the fibroblasts can be separated together in the process of separating stem cells from adipose tissue.

한편, 상기에서 수득한 인간 지방조직 유래 줄기세포액으로부터 목적의 표면항원을 발현하고 있는 다분화능 줄기세포를 수득하는 방법으로서는 소팅 기능을 가진 플로우 사이토미터를 사용한 FACS 법 (Int . Immunol ., 10(3):275, 1998), 자기 비즈를 사용하는 방법, 다분화능 줄기세포를 특이적으로 인식하는 항체를 사용한 패닝법 (J. Immunol ., 141(8):2797, 1998) 등이 있다. 또한, 대량의 배양액 등으로부터 다분화능 줄기세포를 수득하는 방법으로서는, 세포의 표면에 발현되어 분자(이하, 표면 항원이라 칭함)를 특이적으로 인식하는 항체를 단독 또는 조합하여 이 를 칼럼으로서 사용하는 방법이 있다. On the other hand, the FACS method using a flow cytometer with a sorting function ( Int . Immunol . , 10 (3) was used as a method for obtaining multipotent stem cells expressing the surface antigens of interest from the stem cell fluid derived from human adipose tissue obtained above . : 275, 1998), methods using magnetic beads, and panning methods using antibodies that specifically recognize multipotent stem cells ( J. Immunol . , 141 (8): 2797, 1998). In addition, as a method for obtaining multipotent stem cells from a large amount of culture solution or the like, antibodies which are expressed on the surface of cells and specifically recognize molecules (hereinafter referred to as surface antigens) are used alone or in combination and used as columns. There is a way.

플로우 사이토미터 소팅 방식으로서는, 수적하전 방식, 셀캡쳐 방식 등을 들 수 있다. 어떠한 방법도 세포의 표면항원을 특이적으로 인식하는 항체를 형광으로 표지하고, 표지된 항체와 항원의 결합체에 대한 형광을 측정하여 형광 강도를 전기 신호로 변환함으로서 세포의 항원 발현량을 정량할 수 있다. 또한, 사용하는 형광물질의 종류를 조합함으로서, 복수의 표면 항원을 발현하고 있는 세포를 분리하는 것도 가능하다. 여기에 사용가능한 형광물질로는, FITC (fluorescein isothiocyanate), PE (phycoerythrin), APC (allo-phycocyanin), TR (TexasRed), Cy3, CyChrome, Red613, Red670, TRI-Color, QuantumRed 등이 있다. Examples of the flow cytometer sorting method include a water charge method, a cell capture method, and the like. Any method can quantitate the amount of antigen expressed in a cell by labeling an antibody that specifically recognizes the surface antigen of the cell with fluorescence, and converting the fluorescence intensity into an electrical signal by measuring the fluorescence of a conjugate of the labeled antibody and antigen. have. In addition, by combining the kinds of fluorescent materials to be used, it is possible to separate cells expressing a plurality of surface antigens. Fluorescent materials usable herein include FITC (fluorescein isothiocyanate), PE (phycoerythrin), APC (allo-phycocyanin), TR (TexasRed), Cy3, CyChrome, Red613, Red670, TRI-Color, QuantumRed and the like.

플로우 사이토미터를 사용한 FACS 법으로서는, 상기에서 수득한 줄기세포용액을 수집하고, 원심분리 등의 방법으로 세포를 분리한 후, 직접 항체로 염색하는 방법과 한번 적당한 배지 중에서 배양, 증식을 실시한 후에 항체를 염색하는 방법을 이용할 수 있다. 세포의 염색은 우선, 표면 항원을 인식하는 일차항체와 목적 세포샘플을 혼합하고, 얼음 위에서 30분 내지 1시간 인큐베이션한다. 일차 항체가 형광으로 표지되어 있는 경우에는 세정 후 플로우 사이토미터로 분리를 실시한다. 일차 항체가 형광 표지되어 있지 않는 경우에는 세정 후 일차 항체에 대해서 결합 활성을 갖는 형광 표지된 이차 항체와 일차 항체가 반응한 세포를 혼합하고, 다시 얼음물에서 30분 내지 1시간 인큐베이션한다. 세정 후, 일차 항체와 이차 항체에서 염색된 세포를 플로우 사이토미터로 분리를 실시한다. As a FACS method using a flow cytometer, the stem cell solution obtained above is collected, the cells are separated by centrifugation or the like, and then stained with an antibody directly, and cultured and propagated in a suitable medium once, followed by antibody. The method of dyeing can be used. To stain the cells, firstly, the primary antibody recognizing the surface antigen and the desired cell sample are mixed and incubated for 30 minutes to 1 hour on ice. If the primary antibody is labeled with fluorescence, it is separated by a flow cytometer after washing. In the case where the primary antibody is not fluorescently labeled, after washing, the fluorescently labeled secondary antibody having a binding activity to the primary antibody and the cells reacted with the primary antibody are mixed and incubated in ice water for 30 minutes to 1 hour. After washing, the cells stained with the primary antibody and the secondary antibody are separated by flow cytometry.

본 발명에 따른 인간 지방 조직 유래 성체 줄기세포, 섬유 아세포 및 지방을 함유하는 조성물은 피부 탄력을 높이고, 주름 특히 얼굴의 팔자 주름 및 미간주름과 피부 처짐을 개선하며, 함몰부위를 성형을 통해 복구하도록 함으로써 미용에 효과적이다. 아울러, 상기 인간 지방 조직 유래 성체 줄기세포는 지방세포로 분화할 수 있으므로 본 발명에 따른 조성물은 유방 조직 형성 등에도 유용하다.The composition containing the adult adipose stem cells, fibroblasts and fat derived from human adipose tissue according to the present invention improves skin elasticity, improves wrinkles, especially the nasolabial folds and brow wrinkles and skin sagging, and restores the dents through molding. It is effective for beauty. In addition, since the adult adipose stem cells derived from human adipose tissue can be differentiated into adipocytes, the composition according to the present invention is also useful for forming breast tissue.

이하, 실시예를 통하여 본 발명을 더욱 상세히 설명하고자 한다. 이들 실시예는 오로지 본 발명을 예시하기 위한 것으로, 본 발명의 범위가 이들 실시예에 의해 제한되는 것으로 해석되지 않는 것은 당업계에서 통상의 지식을 가진 자에게 있어서 자명할 것이다. Hereinafter, the present invention will be described in more detail with reference to Examples. These examples are only for illustrating the present invention, and it will be apparent to those skilled in the art that the scope of the present invention is not to be construed as being limited by these examples.

실시예Example 1 : 지방조직에서  1: in adipose tissue 다분화능Multiplicity 성체 줄기세포의 분리 및 성형용 조성물의 제조 Isolation and Molding of Adult Stem Cells

제조예Production Example 1 One

인간 지방조직의 지방흡입술(liposuction)에서 부수적으로 얻어지는 생리식염수에 부유된 지방함유 suspension을 적정양의 생리식염수로 고르게 재부유하여 세포배양용 flask 또는 roller bottle에 적당량을 넣은 다음, 정치 배양 또는 회전배양을 하였다. 정치 배양의 경우, 최소 6시간 내지 12시간 동안 정치하였다. 그 다음으로, 플라스크 표면에 부착되는 세포층(지방유래 MSC, fibroblast)을 트립신으로 처리하여 회수하였다 (도 1). 이때, 소량의 생리식염수에 부유된 것을 직접 회수하여 바로 사용하거나, 세포층의 부피를 줄이고자 할 경우, 상기 생리식염수로 회수한 세포층을 1000rpm에서 10분간 원심분리하여 가라앉는 펠렛층만을 사용하였다. 상기 분리된 세포층에는 성체줄기세포와 섬유아세포가 함유되어 있다. 상기 분리된 세포층을 지방과 혼합하여 본 발명에 따른 성체 줄기세포, 섬유아세포 및 지방 또는 지방세포를 함유하는 피부 미용 또는 성형용 조성물을 제조하였다. The fat-containing suspension suspended in physiological saline obtained by liposuction of human adipose tissue is resuspended evenly with an appropriate amount of physiological saline and placed in an appropriate amount in a cell culture flask or roller bottle, followed by stationary culture or rotary culture. Was done. For stationary cultivation, it was left for at least 6 to 12 hours. Next, the cell layer (fat-derived MSC, fibroblast) attached to the flask surface was recovered by treatment with trypsin (FIG. 1). At this time, to directly recover the suspended in a small amount of physiological saline, or to reduce the volume of the cell layer, only the pellet layer was used by centrifuging the cell layer recovered with physiological saline for 10 minutes at 1000 rpm. The separated cell layer contains adult stem cells and fibroblasts. The separated cell layer was mixed with fat to prepare a composition for skin beauty or molding containing adult stem cells, fibroblasts and fat or fat cells according to the present invention.

제조예Production Example 2 2

인간 지방조직으로부터 다분화능 줄기세포를 분리 및 정제하였다. 즉, 분리된 인간 지방조직을 PBS로 3번 세척한 다음, 조직을 잘게 자른 후, collagenase type1 (1mg/ml)을 첨가한 DMEM-LG(low glucose) 배지를 이용해 지방과 DMEM을 1:3의 비율로 혼합하여 37℃에서 1시간동안 digestion하였다. PBS로 세척 후 1000rpm에서 5분간 원심분리하였다. 상층액은 suction하고 바닥에 남은 펠렛은 1:1로 혼합한 10%FBS와 DMEM-LG(low glucose)로 세척한 후 1000rpm으로 5분간 원심분리하였다. 100㎛ mesh에 필터링하여 debris를 제거한 후 PBS로 세척하였다. DMEM(10% FBS, 2mM NAC, 0.2mM ascorbic acid) 배지에 인큐베이션하였다. 하룻밤 지난 후 붙지않은 세포들은 PBS로 세척하고, K-NAC media(Keratinocyte-SFM media + 2mM NAC + 0.2mM ascorbic acid + 0.09mM calcium + 5ng/ml rEGF + 50㎍/ml BPE + 5㎍/ml insulin + 74ng/ml hydrocortisone)를 2일마다 교체하면서 배양하여 인간 지방조직 유래 다분화능 줄기세포 및 섬유아세포액을 수득하였다. 상기 수득된 세포에 지방을 혼합하여 본 발명에 따른 성체 줄기세포, 섬유아세포 및 지방 또는 지방세포를 함유하는 피부 미용 또는 성형용 조성물을 제조하였다. Multipotent stem cells were isolated and purified from human adipose tissue. In other words, separated human adipose tissue was washed three times with PBS, and then the tissue was chopped, and then the fat and DMEM were 1: 3 using DMEM-LG (low glucose) medium to which collagenase type1 (1 mg / ml) was added. The mixture was mixed at a ratio and digested at 37 ° C. for 1 hour. After washing with PBS, centrifugation was performed for 5 minutes at 1000 rpm. The supernatant was suctioned and the pellet remaining on the bottom was washed with 10% FBS and DMEM-LG (low glucose) mixed 1: 1 and centrifuged at 1000 rpm for 5 minutes. After filtering to 100㎛ mesh to remove the debris and washed with PBS. Incubated in DMEM (10% FBS, 2 mM NAC, 0.2 mM ascorbic acid) medium. After overnight, non-stick cells were washed with PBS and K-NAC media (Keratinocyte-SFM media + 2 mM NAC + 0.2 mM ascorbic acid + 0.09 mM calcium + 5 ng / ml rEGF + 50 µg / ml BPE + 5 µg / ml insulin) + 74ng / ml hydrocortisone) was replaced every 2 days to obtain multipotent stem cells and fibroblasts derived from human adipose tissue. Fat was mixed with the obtained cells to prepare a composition for cosmetic or molding skin containing adult stem cells, fibroblasts and fat or adipocytes according to the present invention.

실시예Example 2: 지방 유래  2: derived from fat 다분화능Multiplicity 줄기세포의 면역학적 특성 Immunological Characteristics of Stem Cells

실시예 1에서 수득한 지방조직 유래 성체 줄기세포를 PBS로 세척하고, 트립신 처리한 뒤 세포를 수거하여 5분 동안 1000rpm으로 4℃에서 원심분리하였다. 상층액을 버린 후 2% FBS 및 PBS의 혼합액을 넣어서 세척한 후 1000rpm으로 5분동안 4℃에서 원심분리하였다. 상층액을 버린 후 세포를 PBS에 부유시켜 sample수 만큼 1 ×105 cells을 분주한 후 1000rpm으로 5분동안 4℃에서 원심분리한 후, 상층액을 제거하고 150㎕의 블로킹용액 (5% FBS in PBS)을 넣은 후 잘 혼합하여 1000rpm으로 5분동안 4℃에서 원심분리하였다. 다시 상층액을 제거하고, 100㎕의 블로킹용액 (5% FBS in PBS)을 넣은 후 잘 혼합하여 4℃에서 30분동안 반응시켰다. 다시 1000rpm으로 5분동안 4℃에서 원심분리한 후, 상층액을 제거하고, 150㎕의 블로킹용액(5% FBS in PBS)을 넣은 후 잘 혼합하고, 각 well에 antibody(R-phycoerythrin-conjugated mouse anti-human monoclonal antibody)를 넣고, 4℃에서 30분동안 반응시켰다. 반응 후에 1000rpm으로 5분동안 4℃에서 원심분리하였다. 상층액을 제거한 뒤 PBS로 세척하고 1000rpm으로 5분동안 4℃에서 원심분리하였다. 다시 한번, 상기 상층액 제거후 PBS로 세척하고 1000rpm에서 5분동안 4℃에서 원심분리하는 과정을 반복하였다. 상층액을 제거한 후 200㎕의 PBS에 잘 섞은 후 1% paraformaldehyde을 넣어서 single화 하고, 플로우 사이토미터를 이용하여 분석하였다. Adipose tissue-derived adult stem cells obtained in Example 1 were washed with PBS, trypsinized, and the cells were harvested and centrifuged at 4 ° C. at 1000 rpm for 5 minutes. The supernatant was discarded and washed with a mixture of 2% FBS and PBS, followed by centrifugation at 4 ° C. for 5 minutes at 1000 rpm. After discarding the supernatant, the cells were suspended in PBS, and 1 × 10 5 cells were dispensed as many as the number of samples. After centrifugation at 4 ° C. for 5 minutes at 1000 rpm, the supernatant was removed and 150 μl of blocking solution (5% FBS). in PBS) and mixed well and centrifuged at 4 ° C. for 5 minutes at 1000 rpm. The supernatant was removed again, 100 μl of blocking solution (5% FBS in PBS) was added and mixed well, followed by reaction at 4 ° C. for 30 minutes. After centrifugation at 1000 ° C. for 5 minutes at 4 ° C., the supernatant was removed, and 150 μl of blocking solution (5% FBS in PBS) was added, mixed well, and antibody (R-phycoerythrin-conjugated mouse) was added to each well. anti-human monoclonal antibody) was added and reacted at 4 ° C. for 30 minutes. After the reaction, the mixture was centrifuged at 4 ° C. for 5 minutes at 1000 rpm. The supernatant was removed, washed with PBS, and centrifuged at 4 ° C. for 5 minutes at 1000 rpm. Once again, the supernatant was removed, washed with PBS and centrifuged at 4 ° C. for 5 minutes at 1000 rpm. After removing the supernatant and mixed well in 200μl of PBS, 1% paraformaldehyde was added to single and analyzed using a flow cytometer.

지방유래 줄기세포의 표면항원분석(FACS analysis)Surface antigen analysis of adipose derived stem cells (FACS analysis) AntigenAntigen AD-MSCsAD-MSCs CD73CD73 ++ CD90CD90 ++ CD29CD29 ++ CD44CD44 ++ CD105CD105 ++ CD33CD33 -- CD34CD34 -- CD45CD45 -- CD4CD4 -- CD31CD31 -- CD62pCD62p -- CD14CD14 -- HLA-DRHLA-DR --

그 결과, 표 1에서 나타난 바와 같이, 본 발명의 지방조직 유래 성체 줄기세포는 CD73에 대해서는 91%, CD90에 대해서는 97%, CD29에 대해서는 96%, CD44에 대해서는 83%, CD105에 대해서는 80%의 양성반응을 보였다. 또한, 다른 항원에 대한 면역표현형을 확인한 결과, CD33, CD34, CD45, CD4, CD31, CD62p, CD14 및 HLA-DR에 대하여 모두 음성의 면역학적 특성을 나타내었다. As a result, as shown in Table 1, the adipose tissue-derived adult stem cells of the present invention were 91% for CD73, 97% for CD90, 96% for CD29, 83% for CD44, 80% for CD105. It was positive. In addition, as a result of confirming the immunophenotype for other antigens, all showed negative immunological characteristics for CD33, CD34, CD45, CD4, CD31, CD62p, CD14 and HLA-DR.

실시예Example 3: 지방조직 유래 줄기세포의 면역염색분석 3: Immunostaining Analysis of Stem Cells Derived from Adipose Tissue

상기 실시예 1에서 수득된 지방조직 유래 줄기세포를 PBS로 세 번 세척하고, 4% paraformaldehyde을 함유한 PBS로 30분간 고정하였다. PBS로 세 번 세척한 후, 0.1% Triton-X100을 함유한 PBS로 10분간 침투(permeabilization)시킨다. PBS로 세 번 세척한 후, 10% NGS로 1시간동안 반응시키고, 1차항체를 함유한 PBS에 하룻밤동안 반응시킨다. PBS로 3회 세척하고, 2차항체로 암실에서 1시간동안 반응시켰다. PBS로 세 번 세척한 후, mounting하였다. The adipose tissue-derived stem cells obtained in Example 1 were washed three times with PBS and fixed for 30 minutes with PBS containing 4% paraformaldehyde. After washing three times with PBS, it is permeabilized with PBS containing 0.1% Triton-X100 for 10 minutes. After washing three times with PBS, it was reacted with 10% NGS for 1 hour, and reacted overnight with PBS containing the primary antibody. Washed three times with PBS, and reacted with a secondary antibody in the dark for 1 hour. After washing three times with PBS, it was mounted.

그 결과, 도 2에 나타난 바와 같이, 본 발명에 따른 다분화능 줄기세포 스피어는 미분화상태의 세포 마커라고 할 수 있는 Oct4 및 중간엽 줄기세포의 마커인 SH2(CD105), SH3/4(CD73)에 대하여 양성반응을 나타내었다. As a result, as shown in Figure 2, the multipotent stem cell sphere according to the present invention in the SH2 (CD105), SH3 / 4 (CD73), which are markers of Oct4 and mesenchymal stem cells, which can be said to be undifferentiated cell markers. It showed a positive response to.

실시예Example 4: 지방 유래  4: derived from fat 다분화능Multiplicity 줄기세포의 지방세포로의 분화 Differentiation of Stem Cells into Adipocytes

실시예 1에서 수득한 지방조직 유래 다분화능 성체 줄기세포를 5% FBS, 1μM dexamethasone, 200μM indomethacin, 10㎍/ml insulin, 0.5mM IBMX(3-isobutyl-1-methylxanthine)을 함유한 α-MEM 배지에서 2주동안 배양하여 다분화능 줄기세포의 지방세포로의 분화를 유도하고, Oil red O 염색법을 이용하여 분석하였다. 그 결과, 도 3에 나타난 바와 같이, 본 발명에 따른 인간 지방조직 유래 다분화능 줄기세포가 지방세포로 분화된 것을 확인할 수 있었다. Adipocyte-derived multipotent adult stem cells obtained in Example 1 were prepared using α-MEM medium containing 5% FBS, 1 μM dexamethasone, 200 μM indomethacin, 10 μg / ml insulin, and 0.5 mM IBMX (3-isobutyl-1-methylxanthine). The cells were cultured for 2 weeks at to induce differentiation of multipotent stem cells into adipocytes, and analyzed using Oil red O staining. As a result, as shown in Figure 3, it was confirmed that the multipotent stem cells derived from human adipose tissue according to the present invention was differentiated into adipocytes.

실시예Example 5: 지방 유래  5: derived from fat 다분화능Multiplicity 줄기세포를 이용한 동물 실험  Animal experiments using stem cells

마우스를 이용하여, 지방조직 유래 줄기세포의 지방 부피 보존능을 확인하였다. 마우스는 실험군 12 마리와 대조군 12마리를 사용하였으며, 실험군에는 지방1ml와 실시예 1에서 분리된 지방조직 유래 다분화능 성체 줄기세포 및 섬유아세포(5×105/200μl saline)를 마우스에서 피하지방이 없는 부위인 두부피하에 주입하였으며, 대조군에는 지방1ml+vehicle(200ul saline)을 주입하였다.Using mice, fat volume preservation ability of adipose tissue-derived stem cells was confirmed. Mouse was used as a 12 12 test group and control group, the experimental group, the local 1ml as in Example 1 is derived from the adipose tissue isolated from multipotential subcutaneously in adult stem cells and fibroblasts, mouse (5 × 10 5 / 200μl saline ) fat It was injected under the head skin, which is not present, and the control group was injected with 1 ml of fat + vehicle (200ul saline).

15일이 경과한 후, 마우스의 두피를 절개하여 지방을 떼어낸 후, 부피를 측정하였다. 그 결과, 대조군에서는 주입한 지방부피가 31%로 축소된 반면, 실시예 1에서 제조한 조성물을 함께 주입한 실험군에서는 주입한 지방 부피의 45%가 유지되었다. 이 결과로부터 본 발명에 따른 지방조직 유래 줄기세포와 섬유아 세포는 지방 이식술에서 발생되는 지방 부피 저하를 상당히 감소시키는 효과가 있다는 것을 확인할 수 있었다.After 15 days, the scalp of the mouse was incised to remove fat and the volume was measured. As a result, the injected fat volume was reduced to 31% in the control group, while the experimental group injected with the composition prepared in Example 1 maintained 45% of the injected fat volume. From these results, it was confirmed that the adipose tissue-derived stem cells and the fibroblasts according to the present invention have an effect of significantly reducing the fat volume decrease generated in the fat graft.

이상 상세히 기술한 바와 같이, 본 발명은 인간 지방 조직 유래 성체 줄기세포, 섬유아세포 및 지방 또는 지방세포를 함유하는 피부 미용 또는 성형용 조성물을 제공하는 효과가 있다. 본 발명에 따른 피부 미용 또는 성형용 조성물은 피부 탄력을 높이고, 주름 및 피부 처짐을 개선하며, 함몰부위를 성형을 통해 복구하도록 함으로써 미용에 효과적일 뿐만 아니라, 상기 성체 줄기세포가 지방세포로 분화할 수 있어 유방 조직 형성 등에도 유용하다.As described in detail above, the present invention has the effect of providing a composition for cosmetic or cosmetic skin containing adult stem cells, fibroblasts and fat or fat cells derived from human adipose tissue. Skin cosmetic or cosmetic composition according to the present invention to increase the skin elasticity, improve wrinkles and sagging skin, and to restore the depressions by molding as well as effective in beauty, the adult stem cells can be differentiated into fat cells It is also useful for forming breast tissue.

이상으로 본 발명의 내용의 특정한 부분을 상세히 기술하였는 바, 당업계의 통상의 지식을 가진 자에게 있어서, 이러한 구체적 기술은 단지 바람직한 실시양태일 뿐이며, 이에 의해 본 발명의 범위가 제한되는 것이 아닌 점은 명백할 것이다. 따라서, 본 발명의 실질적인 범위는 첨부된 청구항들과 그것들의 등가물에 의하여 정의된다고 할 것이다As described above in detail a specific part of the content of the present invention, for those of ordinary skill in the art, such a specific description is only a preferred embodiment, which is not limited by the scope of the present invention Will be obvious. Therefore, the substantial scope of the present invention will be defined by the appended claims and their equivalents.

Claims (6)

(i) 인간 지방 조직 유래 성체 줄기세포, (ii) 섬유아세포 및 (iii) 지방 또는 지방세포를 함유하는 피부 미용 또는 성형용 조성물. A composition for skin beauty or shaping, comprising (i) adult stem cells derived from human adipose tissue, (ii) fibroblasts, and (iii) fat or fat cells. 제1항에 있어서, 상기 조성물은 유방 조직 형성용 또는 주름제거용인 것을 특징으로 하는 조성물. The composition of claim 1, wherein the composition is for breast tissue formation or wrinkle removal. 다음의 단계를 포함하는, (i) 인간 지방 조직 유래 성체 줄기세포, (ii) 섬유아세포 및 (iii) 지방 또는 지방세포를 함유하는 피부 미용 또는 성형용 조성물의 제조방법: A method for preparing a composition for skin cosmetic or cosmetic composition comprising (i) adult stem cells derived from human adipose tissue, (ii) fibroblasts and (iii) fat or fat cells, comprising the following steps: (a) 인간 지방 조직의 지방흡입술(liposuction)에 의해 얻어진 지방 함유 suspension을 배양용기에서 배양한 다음, 상기 배양용기 표면에 부착된 지방 유래 성체 줄기세포 및 섬유아세포 함유 세포층을 회수하는 단계; 및 (a) culturing the fat-containing suspension obtained by liposuction of human adipose tissue in a culture vessel, and then recovering the adipose-derived adult stem cells and fibroblast-containing cell layers adhered to the culture vessel surface; And (b) 상기 회수된 지방 유래 성체 줄기세포 및 섬유아세포 함유 세포층을 지방 또는 지방세포와 혼합하는 단계. (b) mixing the recovered adipose derived adult stem cells and fibroblast-containing cell layers with fat or adipocytes. 제3항에 있어서, 상기 성체 줄기세포는 중배엽 유래 세포인 것을 특징으로 하는 방법. The method of claim 3, wherein the adult stem cells are mesodermal derived cells. 제3항에 있어서, 상기 지방 유래 성체 줄기세포는 덱사메타손 (dexamethasone), 인도메타신 (indomethacin), 인슐린 및 IBMX를 함유한 α-MEM 배지에서 배양하여 지방세포로 분화되는 것을 특징으로 하는 방법. 4. The method of claim 3, wherein the adipose derived adult stem cells are cultured in α-MEM medium containing dexamethasone, indomethacin, insulin and IBMX to differentiate into adipocytes. 다음의 단계를 포함하는 (i) 인간 지방 조직 유래 성체 줄기세포, (ii) 섬유아세포 및 (iii) 지방 또는 지방세포를 함유하는 피부 미용 또는 성형용 조성물의 제조방법: A method for preparing a composition for cosmetic or cosmetic treatment comprising (i) adult stem cells derived from human adipose tissue, (ii) fibroblasts and (iii) fat or fat cells, comprising the following steps: (a) 인간 지방조직 유래 펠렛을 NAC(N-acetyl-L-cysteine) 함유 배지에서 배양하여 지방 유래 성체 줄기세포를 제조한 다음, 지방유래 줄기세포와 섬유아세포를 회수하는 단계; 및 (a) culturing human adipose tissue-derived pellets in NAC (N-acetyl-L-cysteine) -containing medium to prepare adult stem cells, and then recovering adipose derived stem cells and fibroblasts; And (b) 상기 회수된 지방 유래 성체 줄기세포 및 섬유아세포를 지방 또는 지방세포와 혼합하는 단계. (b) mixing the recovered adipose derived adult stem cells and fibroblasts with fat or adipocytes.
KR1020070053275A 2006-06-15 2007-05-31 Cosmetic or Plastic Composition Comprising Multipotent Stem Cells Derived from Human Adipose Tissue, Fibroblast and Adipose or Adiopocyte KR100788632B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020060054071 2006-06-15
KR20060054071 2006-06-15

Publications (2)

Publication Number Publication Date
KR20070119497A true KR20070119497A (en) 2007-12-20
KR100788632B1 KR100788632B1 (en) 2007-12-26

Family

ID=38831918

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020070053275A KR100788632B1 (en) 2006-06-15 2007-05-31 Cosmetic or Plastic Composition Comprising Multipotent Stem Cells Derived from Human Adipose Tissue, Fibroblast and Adipose or Adiopocyte

Country Status (4)

Country Link
JP (1) JP2009539546A (en)
KR (1) KR100788632B1 (en)
CN (1) CN101473030A (en)
WO (1) WO2007145438A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009136747A2 (en) * 2008-05-07 2009-11-12 한 쎌 주식회사 Cosmetic composition comprising a stem-cell culture fluid, and a production method therefor
WO2012074265A2 (en) * 2010-11-29 2012-06-07 주식회사 알앤엘바이오 Composition for promoting the stability of stem cells
US9211306B2 (en) 2007-11-30 2015-12-15 Rnl Bio Co., Ltd. Cellular therapeutic agent for incontinence or urine comprising stem cells originated from decidua or adipose

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2039348A1 (en) * 2007-09-21 2009-03-25 Jürgen Schliefelbein Cosmetic preparation and method to obtain a somatic stem cell preparation
KR20100008763A (en) * 2008-07-16 2010-01-26 주식회사 알앤엘바이오 Cosmetic composition comprising matrials cultured multipotent stem cells derived from adipose tissue and proteins extracted therefrom
JP2010178830A (en) * 2009-02-04 2010-08-19 Olympus Corp Live organ transplant material and method for manufacturing the same
WO2011062313A1 (en) 2009-11-17 2011-05-26 Lee Hee Young Method for separating stem cells
CN101785853B (en) * 2010-03-24 2013-02-27 晏泽 Mesenchymal stem cell biological winkle removing agent and preparation method thereof
KR20130061658A (en) * 2011-12-01 2013-06-11 주식회사 알앤엘바이오 Medium composition for preparing deaged stem cells
KR101523040B1 (en) * 2012-06-26 2015-05-26 라정찬 Method for Preparing High Concentration of Stem Cells
KR101588394B1 (en) 2013-05-09 2016-01-25 라정찬 Media Composition for Improving Renewal Ability and Method for Culturing Stem Cells Using the Same
WO2016072821A1 (en) * 2014-11-07 2016-05-12 한양대학교 에리카산학협력단 Composition for differentiation induction of adipocyte containing stem cell-derived exosome, regeneration of adipose tissue, and skin whitening or wrinkle improvement
CN111773173B (en) * 2014-11-07 2024-03-22 胞外体干细胞株式会社 Composition for inducing adipogenic differentiation, regenerating adipose tissue, whitening skin or improving wrinkles comprising stem cell-derived exosomes
CN104814788A (en) * 2015-03-21 2015-08-05 李玉欣 Plastic-surgery treatment device
JP6718440B2 (en) * 2015-05-29 2020-07-08 ロート製薬株式会社 Beauty method and skin external preparation used therefor, migration-imparting agent, and screening method for components used in beauty method for improving skin condition
KR101590498B1 (en) 2015-07-06 2016-02-01 김성남 Cosmetic Composition Using Stem Cell For Setting Prosthesis After Plastic Operation and Tissue Regenaration in Operation Part, and Cosmetic Product Comprising the Same
CN110396497A (en) * 2019-07-31 2019-11-01 北京添易医学研究院 Preparation and beauty method based on autologous fat stem cell excretion body

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030082152A1 (en) * 1999-03-10 2003-05-01 Hedrick Marc H. Adipose-derived stem cells and lattices
PT1261694E (en) * 2000-02-26 2008-04-03 Artecel Inc Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof
US20030161816A1 (en) * 2001-12-07 2003-08-28 Fraser John K. Systems and methods for treating patients with processed lipoaspirate cells
EP1496978A4 (en) 2002-04-03 2006-11-29 Artecel Sciences Inc Improvements of adipocytic differentiated adipose derived adult stem cells and uses thereof
US20040101959A1 (en) * 2002-11-21 2004-05-27 Olga Marko Treatment of tissue with undifferentiated mesenchymal cells
CA2529954A1 (en) * 2003-06-18 2005-02-10 Macropore Biosurgery, Inc. Methods of using adipose tissue-derived cells in augmenting autologous fat transfer
JP4749331B2 (en) * 2003-10-07 2011-08-17 株式会社バイオマスター Cell differentiation of adipose-derived progenitor cells
US9631176B2 (en) * 2003-11-04 2017-04-25 Biomaster, Inc. Method for preparing stem cells from fat tissue
JPWO2005121320A1 (en) * 2004-06-10 2008-04-10 協和醗酵工業株式会社 Stem cell self-renewal promoter
WO2006074075A2 (en) * 2004-12-30 2006-07-13 Primegen Biotech, Llc Adipose-derived stem cells for tissue regeneration and wound healing
KR100811537B1 (en) * 2005-03-11 2008-03-20 양영일 Manufacturing method and it's delivery method of creation and it's remedy of fatty tissue therapeutics
KR20070000005A (en) * 2005-06-24 2007-01-02 주식회사 아디포랩 Cosmetic composition containing fibroblast growth factor
KR100679642B1 (en) * 2005-11-16 2007-02-06 주식회사 알앤엘바이오 Multipotent stem cell derived from human adipose tissue and cellular therapeutic agents comprising the same

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9211306B2 (en) 2007-11-30 2015-12-15 Rnl Bio Co., Ltd. Cellular therapeutic agent for incontinence or urine comprising stem cells originated from decidua or adipose
WO2009136747A2 (en) * 2008-05-07 2009-11-12 한 쎌 주식회사 Cosmetic composition comprising a stem-cell culture fluid, and a production method therefor
WO2009136747A3 (en) * 2008-05-07 2010-02-18 한 쎌 주식회사 Cosmetic composition comprising a stem-cell culture fluid, and a production method therefor
WO2012074265A2 (en) * 2010-11-29 2012-06-07 주식회사 알앤엘바이오 Composition for promoting the stability of stem cells
WO2012074265A3 (en) * 2010-11-29 2012-08-23 주식회사 알앤엘바이오 Composition for promoting the stability of stem cells

Also Published As

Publication number Publication date
CN101473030A (en) 2009-07-01
KR100788632B1 (en) 2007-12-26
JP2009539546A (en) 2009-11-19
WO2007145438A1 (en) 2007-12-21

Similar Documents

Publication Publication Date Title
KR100788632B1 (en) Cosmetic or Plastic Composition Comprising Multipotent Stem Cells Derived from Human Adipose Tissue, Fibroblast and Adipose or Adiopocyte
DK2292736T3 (en) Identification and isolation of multipotent cells from non-osteochondral mesenchymal tissue
EP1948786B1 (en) Multipotent stem cells derived from human adipose tissue and cellular therapeutic agents comprising the same
EP2205724B1 (en) Method for isolating and culturing adult stem cells derived from human amniotic epithelium
Jackson et al. Mesenchymal progenitor cells derived from traumatized human muscle
EP1788079A1 (en) Animal tissue-eccentrically located pluripotent cell proliferating selectively in low-serium medium
KR20120008223A (en) Medium for culturing mesenchymal stem cells derived from amnion and method for culturing mesenchymal stem cells derived from amnion using thereof
US20120288480A1 (en) Cell population comprising orbital fat-derived stem cells (ofscs) and their isolation and applications
JP6410343B2 (en) Induction from adipose tissue-derived stem cells into epidermal keratinocytes
KR20140016841A (en) A novel stem cell source derived from fetal cartilage tissue and cellular therapeutic agent
KR20100025658A (en) Composition comprising differentiated immature adipose cells for regeneration of soft tissue
TWI573873B (en) Serum-free culture expansion of somatic stem/progenitor cells in vitro
KR100818216B1 (en) Multipotent stem cell or cancer stem cell simultaneously expressing cripto-1 and oct4 derived from human adipose tissue or cancer and method for identifying the same
US20120094379A1 (en) Human endometriosis cell
AU2011253985B2 (en) Identification and isolation of multipotent cells from non-osteochondral mesenchymal tissue
US20130130381A1 (en) Method for obtaining a population of stromal progenitor cells
Halim et al. Adipose-derived stem cells in tissue engineering: laboratory to bedside
US20140302605A1 (en) Method of obtaining a population of cells
Mohammed et al. The Role of Donor’s Age on the Proliferation and Osteogenic Differentiation of Human Dental Pulp stem cells Eman EA Mohammed1, 3, Mohamed El-Zawahry2, Nahla N. Abdel Aziz1, Nourhan Abu-Shahba1, 3, Marwa Mahmoud1, 3 and Alice K. Abdel Aleem1, 3, 4

Legal Events

Date Code Title Description
A201 Request for examination
A302 Request for accelerated examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20121107

Year of fee payment: 6

FPAY Annual fee payment

Payment date: 20131126

Year of fee payment: 7

FPAY Annual fee payment

Payment date: 20141119

Year of fee payment: 8

LAPS Lapse due to unpaid annual fee